- Home
- PPBT vs SVRE Comparison
PPBT vs SVRE Comparison
Compare PPBT & SVRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PPBT | SVRE |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | Israel | Israel |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4M | 3.7M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | PPBT | SVRE |
|---|---|---|
| Price | $2.89 | $4.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | ★ 31.6K | 26.7K |
| Earning Date | 05-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,793.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $0.55 |
| 52 Week High | $5.18 | $6.30 |
Technical Indicators
Market Signals| Indicator | PPBT | SVRE |
|---|---|---|
| Relative Strength Index (RSI) | 32.32 | 46.86 |
| Support Level | $0.57 | $1.03 |
| Resistance Level | $4.39 | $4.92 |
| Average True Range (ATR) | 0.32 | 0.62 |
| MACD | -0.16 | -0.18 |
| Stochastic Oscillator | 17.53 | 10.16 |
Price Performance
Historical ComparisonAbout PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd is engaged in the design, development, and commercialization of transportation and safety solutions, designed to prevent car accidents based on its patented technology of detecting, analyzing, and locating cellular phone radio frequency, or RF signals. The company is developing two product lines: the first is an In-Cabin Driver Distraction Prevention Solution (known as SaverOne system), or DDPS; and the second is an Advanced Driver-Assistance System, or ADAS, product that detects vulnerable road users, or VRUs, and provides a warning to the vehicle regarding potential collision. Geographically, Saverone generates maximum revenue from Europe and the rest from Israel.